Literature DB >> 20648549

Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Okkyung Rho1, Dae Joon Kim, Karou Kiguchi, John Digiovanni.   

Abstract

Growth factor receptor (GFR) signaling controls epithelial cell growth by responding to various endogenous or exogenous stimuli and subsequently activating downstream signaling pathways including Stat3, PI3K/Akt/mTOR, MAPK, and c-Src. Environmental chemical toxicants and UVB irradiation cause enhanced and prolonged activation of GFR signaling and downstream pathways that contributes to epithelial cancer development including skin cancer. Recent studies, especially those with tissue-specific transgenic mouse models, have demonstrated that GFRs and their downstream signaling pathways contribute to all three stages of epithelial carcinogenesis by regulating a wide variety of biological functions including proliferation, apoptosis, angiogenesis, cell adhesion, and migration. Inhibiting these signaling pathways early in the carcinogenic process results in reduced cell proliferation and survival, leading to decreased tumor formation. Collectively, these studies suggest that GFR signaling and subsequent downstream signaling pathways are potential targets for the prevention of epithelial cancers including skin cancer.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20648549      PMCID: PMC3005141          DOI: 10.1002/mc.20665

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  207 in total

1.  A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes.

Authors:  Z Dong; H C Crawford; V Lavrovsky; D Taub; R Watts; L M Matrisian; N H Colburn
Journal:  Mol Carcinog       Date:  1997-07       Impact factor: 4.784

2.  Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation.

Authors:  A V Khokhlatchev; B Canagarajah; J Wilsbacher; M Robinson; M Atkinson; E Goldsmith; M H Cobb
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

Review 3.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

Review 4.  PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond.

Authors:  B M Marte; J Downward
Journal:  Trends Biochem Sci       Date:  1997-09       Impact factor: 13.807

5.  Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter.

Authors:  D Bol; K Kiguchi; L Beltrán; T Rupp; S Moats; I Gimenez-Conti; J Jorcano; J DiGiovanni
Journal:  Mol Carcinog       Date:  1998-01       Impact factor: 4.784

6.  Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B.

Authors:  L Stephens; K Anderson; D Stokoe; H Erdjument-Bromage; G F Painter; A B Holmes; P R Gaffney; C B Reese; F McCormick; P Tempst; J Coadwell; P T Hawkins
Journal:  Science       Date:  1998-01-30       Impact factor: 47.728

7.  Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

Authors:  J M Chan; M J Stampfer; E Giovannucci; P H Gann; J Ma; P Wilkinson; C H Hennekens; M Pollak
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

8.  K-ras is an essential gene in the mouse with partial functional overlap with N-ras.

Authors:  L Johnson; D Greenbaum; K Cichowski; K Mercer; E Murphy; E Schmitt; R T Bronson; H Umanoff; W Edelmann; R Kucherlapati; T Jacks
Journal:  Genes Dev       Date:  1997-10-01       Impact factor: 11.361

9.  Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.

Authors:  J J Li; J S Rhim; R Schlegel; K H Vousden; N H Colburn
Journal:  Oncogene       Date:  1998-05-28       Impact factor: 9.867

10.  Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.

Authors:  B C Turner; B G Haffty; L Narayanan; J Yuan; P A Havre; A A Gumbs; L Kaplan; J L Burgaud; D Carter; R Baserga; P M Glazer
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

View more
  33 in total

1.  Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model.

Authors:  Sanjeev Shukla; Gregory T MacLennan; Pingfu Fu; Sanjay Gupta
Journal:  Pharm Res       Date:  2011-12-03       Impact factor: 4.200

2.  Nitric oxide donor exisulind is an effective inhibitor of murine photocarcinogenesis.

Authors:  Tripti Singh; Sandeep C Chaudhary; Puneet Kapur; Zhiping Weng; Craig A Elmets; Levy Kopelovich; Mohammad Athar
Journal:  Photochem Photobiol       Date:  2012-02-24       Impact factor: 3.421

3.  Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  L Allyson Checkley; Okkyung Rho; Tricia Moore; Steve Hursting; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

4.  c-Yes regulates cell adhesion at the apical ectoplasmic specialization-blood-testis barrier axis via its effects on protein recruitment and distribution.

Authors:  Xiang Xiao; Dolores D Mruk; C Yan Cheng
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-11-20       Impact factor: 4.310

5.  Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild-type and BK5.AktWT mice.

Authors:  Okkyung Rho; Kaoru Kiguchi; Guiyu Jiang; John DiGiovanni
Journal:  Mol Carcinog       Date:  2013-09-20       Impact factor: 4.784

6.  Activation of T-cell protein-tyrosine phosphatase suppresses keratinocyte survival and proliferation following UVB irradiation.

Authors:  Hyunseung Lee; Liza D Morales; Thomas J Slaga; Dae Joon Kim
Journal:  J Biol Chem       Date:  2014-11-18       Impact factor: 5.157

7.  Downregulation of human epidermal growth factor receptor 2 by short hairpin RNA increases chemosensitivity of human ovarian cancer cells.

Authors:  Li Shan Ma; Q I Yan; Yongfang Huang; Wenxia Zhao; Y U Zhu
Journal:  Oncol Lett       Date:  2015-03-12       Impact factor: 2.967

8.  Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.

Authors:  Cornelia Johanna Franziska Scheitz; Tae Seung Lee; David James McDermitt; Tudorita Tumbar
Journal:  EMBO J       Date:  2012-10-02       Impact factor: 11.598

9.  Overexpression of PRAS40(T246A) in the Proliferative Compartment Suppresses mTORC1 Signaling, Keratinocyte Migration, and Skin Tumor Development.

Authors:  Okkyung Rho; Jaya Srivastava; Jiyoon Cho; John DiGiovanni
Journal:  J Invest Dermatol       Date:  2016-06-24       Impact factor: 8.551

10.  Metformin inhibits skin tumor promotion in overweight and obese mice.

Authors:  L Allyson Checkley; Okkyung Rho; Joe M Angel; Jiyoon Cho; Jorge Blando; Linda Beltran; Stephen D Hursting; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.